Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 24.40
-0.35 (-1.41%)
Feb 11, 2026, 2:59 PM CST
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 2.35 billion as of February 13, 2026. Its market cap has increased by 43.02% in one year.
Market Cap
2.35B
Enterprise Value
2.30B
Revenue
821.81M
Ranking
n/a
PE Ratio
24.89
Stock Price
24.40
Market Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.35B, an increase of 84.26%. That is a compound annual growth rate of 3.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.35B | 5.63% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merdury Biopharmaceutical | 3.65B |
| Maywufa Company | 2.90B |
| PhytoHealth | 2.82B |
| Golden Biotechnology | 2.73B |
| Johnson Chemical Pharmaceutical Works | 2.56B |
| LIWANLI Innovation | 2.51B |
| TSH Biopharm Corporation | 2.17B |
| GeneFerm Biotechnology | 1.81B |